Abstract
The perception of pain is the result of complicated physiological and psychological processes. Pain can be treated by interrupting peripheral inputs, or by modulation of pain signals in the central nervous system. One approach that has been particularly successful has involved use of drugs that increase activity in brain and spinal cord pathways that inhibit transmission of pain signals. Drugs that increase serotonin and norepinephrine (Serotonin Norepinephrine Reuptake Inhibitors - SNRIs) have been found to be effective. These drugs are known to have antidepressant activity, and are widely used to treat depression. Although there is overlap between pain and depression, the reason these drugs are effective for treatment of pain appears to result from a direct effect on pain pathways in the central nervous system. Mechanisms of action and clinical utility of SNRIs in treatment of chronic pain are reviewed.
Keywords: serotonin/norepinephrine specific reuptake inhibitors, Diabetic Peripheral Neuropathic Pain, Postherpetic Neuralgia, HIV, Fibromyalgia, Pelvic Pain
Current Drug Therapy
Title: Treatment of Chronic Pain with Drugs that Modulate Central Nervous System Serotonin and Norepinephrine
Volume: 2 Issue: 2
Author(s): Joachim F. Wernicke, Smriti Iyengar and M. Dolores Ferrer-Garcia
Affiliation:
Keywords: serotonin/norepinephrine specific reuptake inhibitors, Diabetic Peripheral Neuropathic Pain, Postherpetic Neuralgia, HIV, Fibromyalgia, Pelvic Pain
Abstract: The perception of pain is the result of complicated physiological and psychological processes. Pain can be treated by interrupting peripheral inputs, or by modulation of pain signals in the central nervous system. One approach that has been particularly successful has involved use of drugs that increase activity in brain and spinal cord pathways that inhibit transmission of pain signals. Drugs that increase serotonin and norepinephrine (Serotonin Norepinephrine Reuptake Inhibitors - SNRIs) have been found to be effective. These drugs are known to have antidepressant activity, and are widely used to treat depression. Although there is overlap between pain and depression, the reason these drugs are effective for treatment of pain appears to result from a direct effect on pain pathways in the central nervous system. Mechanisms of action and clinical utility of SNRIs in treatment of chronic pain are reviewed.
Export Options
About this article
Cite this article as:
Wernicke F. Joachim, Iyengar Smriti and Dolores Ferrer-Garcia M., Treatment of Chronic Pain with Drugs that Modulate Central Nervous System Serotonin and Norepinephrine, Current Drug Therapy 2007; 2 (2) . https://dx.doi.org/10.2174/157488507780619086
DOI https://dx.doi.org/10.2174/157488507780619086 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Renal Function Impairment in Patients Undergoing Elective EVAR vs. Elective Open Repair During Follow up Period: A Systematic Review of the Literature
Current Vascular Pharmacology The Phospholipase A2 Homologues of Snake Venoms: Biological Activities and Their Possible Adaptive Roles
Protein & Peptide Letters Hibiscus Sabdariffa Linnaeus (Malvaceae), Curcumin and Resveratrol as Alternative Medicinal Agents Against Metabolic Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry Targeting Trypanosoma cruzi Platelet-activating Factor Receptors: Scope for the Development of Novel Drugs to Treat Chagas Disease
Mini-Reviews in Medicinal Chemistry Neonatal Systemic Thrombosis: An Updated Overview
Current Vascular Pharmacology Dexmedetomidine Use in General Anaesthesia
Current Drug Targets A New Phospholipase A<sub>2</sub> from Lachesis <i>muta rhombeata</i>: Purification, Biochemical and Comparative Characterization with Crotoxin B
Protein & Peptide Letters The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review
Current Drug Safety Antihypertensive Treatments in Patients Affected by Aortic Valve Stenosis
Current Pharmaceutical Design A Review of the Nephrotoxicity of the Food Flavor Cinnamaldehyde
Current Bioactive Compounds Current Opinions and Perspectives on the Role of Immune System in the Pathogenesis of Parkinson's Disease
Current Pharmaceutical Design Nitric Oxide Pathway as New Drug Targets for Refractory Hypertension
Current Pharmaceutical Design Review of Rational Approaches to the Treatment of Pain Management-Role forOpioids Therapies
Current Drug Therapy Cardiovascular Side Effects of New Antidepressants and Antipsychotics: New Drugs, old Concerns?
Current Pharmaceutical Design Noradrenergic Regulation of Glial Activation: Molecular Mechanisms and Therapeutic Implications
Current Neuropharmacology Toxicological Effects of Dietary Biogenic Amines
Current Nutrition & Food Science Syntheses of Amido-, Carbamido- and Carbamatoalkylnaphthols
Current Organic Synthesis Artificial Blood: A Futuristic Dimension of Modern Day Transfusion Sciences
Cardiovascular & Hematological Agents in Medicinal Chemistry The Development of Medications for Alcohol-Use Disorders Targeting the GABAB Receptor System
Recent Patents on CNS Drug Discovery (Discontinued) Acute Phase Treatment of Pulmonary Embolism
Current Vascular Pharmacology